WHY INVEST IN HOPEC PHARMA?
Investing in Hopec Pharma offers the potential for substantial financial returns while making a meaningful impact.
Our UPEC-FimON therapy addresses a critical unmet need in NMIBC, targeting a growing global market.
Backed by strong science, strategic partnerships, and experienced leadership, Hopec Pharma is uniquely positioned for success, combining profit with purpose.
Key Investment Highlights
Innovation
UPEC-FimON targets a significant unmet need in NMIBC treatment.
Leadership
Leadership with deep expertise in pharma development, global networking, regulation, and clinical trials.
Growth
NMIBC market poised for rapid growth due to rising bladder cancer prevalence.
Development
Phase 1 trials launching Q2 2025 at leading medical centers.
Partnerships
Exclusive partnerships with top institutions like Hebrew University, Hadassah, and Sheba.
Impact
Invest in a mission to enhance patient outcomes and transform global healthcare.
GOVERNANCE
At Hopec Pharma, strong governance is the cornerstone of our mission. We are committed to transparency, accountability, and ethical conduct across all operations.
Board of Directors
We are assembling a Board of Directors composed of industry leaders who will guide our strategic direction, ensuring alignment with our mission and long-term goals.
Advisory Board
Our Advisory Board consists of experts in oncology, drug development, business growth, and commercialization.
Their insights are crucial in shaping our clinical strategy and driving innovation.
Leadership Team
Co-Founders Gadi Klarsfeld (CEO) and Estee Rosen (COO) lead a team with deep expertise in pharmaceutical development, regulatory affairs, and global networking.
Ethical Standards
We maintain the highest ethical standards, ensuring regulatory compliance and fostering trust with all stakeholders.
Transparency
We are dedicated to open communication, regularly providing updates and reports to our investors, partners, and stakeholders.
NEWS AND UPDATES
Stay updated on Hopec Pharma's latest developments, including research, clinical trials, partnerships, and milestones. We'll share significant announcements, strategic initiatives, and media coverage, along with press releases and project updates. Our goal is to keep stakeholders informed about our progress and impact in cancer treatment.